期刊
JOURNAL OF NEUROCHEMISTRY
卷 103, 期 6, 页码 2462-2470出版社
WILEY
DOI: 10.1111/j.1471-4159.2007.04942.x
关键词
Alzheimer disease; calpain; cAMP-response; element-binding protein; protein kinase
资金
- NIA NIH HHS [P30 AG19610, R01 AG027429, R01 AG027429-01, AG027429, R01 AG027429-02, AG019158, P30 AG019610, R01 AG019158] Funding Source: Medline
Impaired cognition and memory may be associated with down-regulation of cAMP-response element-binding protein (CREB) in the brain in patients with Alzheimer disease, but the molecular mechanism leading to the down-regulation is not understood. In this study, we found a selective reduction in the levels of the regulatory subunits (RII alpha and RII beta) and the catalytic subunit (C beta) as well as the enzymatic activity of cAMP-dependent protein kinase (PKA), which is the major positive regulator of CREB. We also observed that PKA subunits were proteolyzed by calpain and the levels of PKA subunits correlated negatively with calpain activation in the human brain. These findings led us to propose that in the brain in patients with Alzheimer disease, over-activation of calpain because of calcium dysregulation causes increased degradation and thus decreased activity of PKA, which, in turn, contributes to down-regulation of CREB and impaired cognition and memory.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据